Hidroksikarbamida (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hidroksikarbamida" in Malay language version.

refsWebsite

Global rank Malay rank

16nih.gov

4^th place

14^th place

12doi.org

2^nd place

8^th place

4wikipedia.org

low place

3web.archive.org

1^st place

1drugs.com

399^th place

730^th place

1medicines.org.uk

3,823^rd place

5,861^st place

1handle.net

102^nd place

419^th place

1ijdvl.com

low place

1archive.org

6^th place

27^th place

1fda.gov

447^th place

467^th place

1mercksource.com

8,363^rd place

625^th place

1zenodo.org

621^st place

1,190^th place

1espacenet.com

800^th place

5,553^rd place

archive.org

Longe JL (2002). Gale Encyclopedia Of Cancer: A Guide To Cancer And Its Treatments. Detroit: Thomson Gale. m/s. 514–516. ISBN 978-1-4144-0362-5.

doi.org

"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia". The New England Journal of Medicine. 353 (1): 33–45. July 2005. doi:10.1056/NEJMoa043800. PMID 16000354. Unknown parameter |displayauthors= ignored (bantuan)
"Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease". Annals of Internal Medicine. 148 (12): 939–955. June 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMC 3256736. PMID 18458272. Unknown parameter |displayauthors= ignored (bantuan)
"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients". The Journal of Allergy and Clinical Immunology. 124 (3): 514–521. September 2009. doi:10.1016/j.jaci.2009.05.003. PMID 19541349. Unknown parameter |displayauthors= ignored (bantuan)
"Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis". Health Technology Assessment. 8 (28): iii, 1-iii120. July 2004. doi:10.3310/hta8280. PMID 15245690.
"NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea". Birth Defects Research. Part B, Developmental and Reproductive Toxicology. 80 (4): 259–366. August 2007. doi:10.1002/bdrb.20123. PMID 17712860. Unknown parameter |displayauthors= ignored (bantuan)
"Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. March 2008. doi:10.1056/NEJMct0708272. PMID 18367739.
"Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase". The Journal of Clinical Investigation. 111 (2): 231–239. January 2003. doi:10.1172/JCI16672. PMC 151872. PMID 12531879.
"Plasma hydroxyurea determined by gas chromatography-mass spectrometry". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 877 (4): 446–450. February 2009. doi:10.1016/j.jchromb.2008.12.048. PMID 19144580.
"Ueber den Hydroxylharnstoff". Justus Liebigs Ann. Chem. 150 (2): 1317–22. 1869. doi:10.1002/jlac.18691500212.
"The rationale for using hydroxycarbamide in the treatment of sickle cell disease". Haematologica. 96 (4): 488–491. April 2011. doi:10.3324/haematol.2011.041988. PMC 3069221. PMID 21454878.
"New Method for Synthesis of Hydroxyurea and Some of its Polymer Supported Derivatives As New Controlled Release Drugs". Journal of Basrah Research. 41 (1). 2016. doi:10.13140/RG.2.1.3607.2720.
"Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools". The Journal of Biological Chemistry. 279 (1): 223–230. January 2004. doi:10.1074/jbc.M303952200. PMID 14573610.^{[pautan mati]}

drugs.com

"Hydroxyurea". The American Society of Health-System Pharmacists. Dicapai pada 8 December 2016.

espacenet.com

worldwide.espacenet.com

US, "Synthesis of Ureas"

fda.gov

accessdata.fda.gov

"HYDREA" (PDF). Accessdata.fda.gov. US Food and Drug Administration.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

ijdvl.com

"Hydroxyurea as an alternative therapy for psoriasis". Indian Journal of Dermatology, Venereology and Leprology. 70 (1): 13–17. 2004. PMID 17642550. Diarkibkan daripada yang asal pada 2009-07-03.

medicines.org.uk

"Hydrea 500 mg Hard Capsules – Summary of Product Characteristics (SPC) – (eMC)". www.medicines.org.uk. Diarkibkan daripada yang asal pada 20 December 2016. Dicapai pada 14 December 2016.

mercksource.com

hydroxyurea di Kamus Perubatan Dorland

nih.gov

pubmed.ncbi.nlm.nih.gov

"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia". The New England Journal of Medicine. 353 (1): 33–45. July 2005. doi:10.1056/NEJMoa043800. PMID 16000354. Unknown parameter |displayauthors= ignored (bantuan)
"Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease". Annals of Internal Medicine. 148 (12): 939–955. June 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMC 3256736. PMID 18458272. Unknown parameter |displayauthors= ignored (bantuan)
"Hydroxyurea as an alternative therapy for psoriasis". Indian Journal of Dermatology, Venereology and Leprology. 70 (1): 13–17. 2004. PMID 17642550. Diarkibkan daripada yang asal pada 2009-07-03.
"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients". The Journal of Allergy and Clinical Immunology. 124 (3): 514–521. September 2009. doi:10.1016/j.jaci.2009.05.003. PMID 19541349. Unknown parameter |displayauthors= ignored (bantuan)
"Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis". Health Technology Assessment. 8 (28): iii, 1-iii120. July 2004. doi:10.3310/hta8280. PMID 15245690.
"NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea". Birth Defects Research. Part B, Developmental and Reproductive Toxicology. 80 (4): 259–366. August 2007. doi:10.1002/bdrb.20123. PMID 17712860. Unknown parameter |displayauthors= ignored (bantuan)
"Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. March 2008. doi:10.1056/NEJMct0708272. PMID 18367739.
"Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase". The Journal of Clinical Investigation. 111 (2): 231–239. January 2003. doi:10.1172/JCI16672. PMC 151872. PMID 12531879.
"Plasma hydroxyurea determined by gas chromatography-mass spectrometry". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 877 (4): 446–450. February 2009. doi:10.1016/j.jchromb.2008.12.048. PMID 19144580.
"The rationale for using hydroxycarbamide in the treatment of sickle cell disease". Haematologica. 96 (4): 488–491. April 2011. doi:10.3324/haematol.2011.041988. PMC 3069221. PMID 21454878.
"Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools". The Journal of Biological Chemistry. 279 (1): 223–230. January 2004. doi:10.1074/jbc.M303952200. PMID 14573610.^{[pautan mati]}
"Mechanism of action of hydroxyurea". Seminars in Oncology. 19 (3 Suppl 9): 1–10. June 1992. PMID 1641648.

ncbi.nlm.nih.gov

"Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease". Annals of Internal Medicine. 148 (12): 939–955. June 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMC 3256736. PMID 18458272. Unknown parameter |displayauthors= ignored (bantuan)
"Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase". The Journal of Clinical Investigation. 111 (2): 231–239. January 2003. doi:10.1172/JCI16672. PMC 151872. PMID 12531879.
"The rationale for using hydroxycarbamide in the treatment of sickle cell disease". Haematologica. 96 (4): 488–491. April 2011. doi:10.3324/haematol.2011.041988. PMC 3069221. PMID 21454878.

pubchem.ncbi.nlm.nih.gov

"Hydroxyurea". PubChem. U.S. National Library of Medicine. Diarkibkan daripada yang asal pada 2017-05-18.

web.archive.org

"Hydrea 500 mg Hard Capsules – Summary of Product Characteristics (SPC) – (eMC)". www.medicines.org.uk. Diarkibkan daripada yang asal pada 20 December 2016. Dicapai pada 14 December 2016.
"Hydroxyurea as an alternative therapy for psoriasis". Indian Journal of Dermatology, Venereology and Leprology. 70 (1): 13–17. 2004. PMID 17642550. Diarkibkan daripada yang asal pada 2009-07-03.
"Hydroxyurea". PubChem. U.S. National Library of Medicine. Diarkibkan daripada yang asal pada 2017-05-18.

wikipedia.org

en.wikipedia.org

"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia". The New England Journal of Medicine. 353 (1): 33–45. July 2005. doi:10.1056/NEJMoa043800. PMID 16000354. Unknown parameter |displayauthors= ignored (bantuan)
"Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease". Annals of Internal Medicine. 148 (12): 939–955. June 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMC 3256736. PMID 18458272. Unknown parameter |displayauthors= ignored (bantuan)
"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients". The Journal of Allergy and Clinical Immunology. 124 (3): 514–521. September 2009. doi:10.1016/j.jaci.2009.05.003. PMID 19541349. Unknown parameter |displayauthors= ignored (bantuan)
"NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea". Birth Defects Research. Part B, Developmental and Reproductive Toxicology. 80 (4): 259–366. August 2007. doi:10.1002/bdrb.20123. PMID 17712860. Unknown parameter |displayauthors= ignored (bantuan)

zenodo.org

"Ueber den Hydroxylharnstoff". Justus Liebigs Ann. Chem. 150 (2): 1317–22. 1869. doi:10.1002/jlac.18691500212.